Damora Therapeutics, Inc. (DMRA)
Recent Filing Index
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Consolidated Statements of Changes In Stockholders' Equity | ||
| Consolidated Statements of Changes In Stockholders' Equity (P) | ||
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accrued Expenses and Other Current Liabilities | ||
| Asset Acquisitions | — |
|
| Asset Purchase Agreement | — |
|
| Commitments and Contingencies | ||
| Cybersecurity Risk Management, Strategy and Governance | — |
|
| Defined Contribution Plan | — |
|
| Description of Business, Organization and Liquidity | ||
| Fair Value Measurements | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Investments | — |
|
| Investments In Marketable Securities | — |
|
| Leases | ||
| Net Loss Per Share | ||
| Pay Vs Performance Disclosure | ||
| Prepaid Expenses and Other Current Assets | ||
| Property and Equipment, Net | ||
| Related Party Transactions | ||
| Restructuring Activies | — |
|
| Restructuring Activities | ||
| Segment Reporting | ||
| Stock-based Compensation | ||
| Stockholders' Equity | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||